|
|
Position:
Vice President, Molecular and Cellular Biology, to apply visit https://jobs.lever.co/vir/32227e1b-d00a-400b-98f9-102c1069c
Employer:
Vir Biotechnology
Description:
RESPONSIBILITIES AND LEARNING OPPORTUNITIES:
- Lead in vitro pharmacology strategy to successfully bring programs from target identification and validation through lead optimization and to the clinic.
- Build a team of highly functioning and collaborative team of scientists and champion a climate of creativity, innovation and scientific excellence.
- Exploration of new targets and novel biology to support internal drug discovery efforts
- Play a major role in developing a project pipeline through internal R&D, collaboration, license-in and/or acquisition in the field of infectious disease. Select the projects based on scientific merit, strategic fit and economic value.
- Accountable for leading internal and external capabilities and to build them to fulfill future needs. This includes oversight of the assay automation core function and novel chemical hit-finding within Vir.
Qualifications/Experience:
QUALIFICATIONS AND EXPERIENCE:
- Preferred education: BA/BS with a minimum of 18 years, or MA/MS with 16 years, or PhD with 13 years of research experience in a relevant industry/academic setting with a focus on infectious disease.
- At least 10 years of management experience preferred.
- Proven track record of advancing discovery projects into early clinical development
- Expertise in discovery and identification of novel therapeutic targets, and the ability to identify and resolve complex methodological issues.
- Comprehensive understanding of drug discovery disciplines outside own core expertise
- Broad knowledge of, and fascination with, cutting-edge technologies and concepts in immunology, infectious diseases and/or immuno-oncology.
- Experience mentoring and developing scientists and creating/maintaining highly collaborative environments while striving for scientific excellence is required.
Location:
San Francisco, CA
Contact:
https://jobs.lever.co/vir/32227e1b-d00a-400b-98f9-102c1069c3bc
Post Date:
4/4/2022 12:00:00 AM
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Allucent
Bringing innovation to Biopharma,w/ClinPharm Modeling & Simulation services to inform dose, design, modeling + development strategies.
|
|
BioTether Sciences
Contract development, validation and regulated testing. Advanced cell engineering. Bioanalysis of cells, genes, and proteins.
|
Origin Bioanalytical Laboratory, Inc.
Bioanalytical CRO specializing in LC-MS/MS method development, validation, non-GLP and GLP analysis to support PK/TK studies, with ocular expertise.
|
Hypha Discovery
Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
|
Alturas Analytics, Inc.
Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
|
Submit a Text Ad
|